glp 1 effect on gallbladder issues GLP-1 receptor agonists and disease risk: insights into molecular mechanisms and clinical implications GLP-1 and Increased Incidence of – GLP-1 and Gut Health: Addressing

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials

GLP-1 agonists are being used in combination with basal insulin (Dungan & DeSantis, 2016), although this is not an FDA-approved indication (see rxlist.com) they should not be used as a substitute for basal insulin, as this has been found to result in a decline in glycemic control)(Dungan & DeSantis, 2016) Clinical trials indicate it can reduce HbA1c by ~0.8% Undergoes renal clearance, with dosage reduction needed if creatinine clearance falls to 1.5

Henry Meds GLP-1 is a telehealth-based weight management program providing online healthcare evaluation and access to prescription GLP-1 treatment options when approved

The Medicare GLP-1 Bridge program represents a historic shift in how the federal government views obesity treatment for beneficiaries, but its not clear what will happen beyond 18 months

Sources U.S